Latest News about locus biosciences
Recent news which mentions locus biosciences
New clinical trial data from Locus Biosciences shows promise in CRISPR-Cas3 technology
March 08, 2021
From TechCrunch
Up to $818 million deal between J&J and Locus Biosciences points to a new path for CRISPR therapies
January 04, 2019
Tickers
TC
From TechCrunch
How Locus landed $19M from ARTIS, Tencent
November 14, 2017
From Business Journals
NCBiotech portfolio companies raise $128M in Q4
August 24, 2017
From Business Journals
From TechCrunch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Market Action
MARKET NEWS
Home | Individual investors | Institutional investors | Find an advisor | Opportunities at Winslow | About | News | Contact | Mobile | Site map
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.